All Stories

  1. Structural profiling of the pneumolysin epitope landscape uncovers a cross-species neutralising site across cholesterol-dependent cytolysins
  2. Capsule Regulation Shapes Klebsiella pneumoniae Pathogenesis by Balancing Adhesion, Biofilm Formation, and Intracellular Survival
  3. Identification of a novel gene associated with group B Streptococcus persister cell formation and biofilm production
  4. Overcoming Immune Evasion in Staphylococcus aureus: Strategies for Rational Vaccine Design
  5. Protection Against Pneumonia Induced by Vaccination with Fimbriae Subunits from Klebsiella pneumoniae
  6. Corynebacteria from the respiratory microbiota modulate inflammatory responses and associate with a reduced pneumococcal burden in the lungs
  7. Pneumococcal surface protein A (PspA) prevents killing of Streptococcus pneumoniae by indolicidin
  8. Role of the polyamine transporter PotABCD during biofilm formation by Streptococcus pneumoniae
  9. Biofilm-dispersed pneumococci induce elevated leukocyte and platelet activation
  10. HAMLET, a human milk protein-lipid complex, modulates amoxicillin induced changes in an ex vivo biofilm model of the oral microbiome
  11. Cannabis use, mental health, and problematic Internet use in Quebec: A study protocol
  12. HAMLET, a human milk protein-lipid complex, modulates amoxicillin-induced changes in anex vivobiofilm model of the oral microbiome
  13. Role of serotype and virulence determinants of Streptococcus pyogenes biofilm bacteria in internalization and persistence in epithelial cells in vitro
  14. Treatment of Mouse Infants with Amoxicillin, but Not the Human Milk-Derived Antimicrobial HAMLET, Impairs Lung Th17 Responses
  15. Measuring Niche-Associated Metabolic Activity in Planktonic and Biofilm Bacteria
  16. Editorial: Microbial biofilms interacting with host mucosal surfaces
  17. A Mouse Model for the Transition of <em>Streptococcus pneumoniae</em> from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
  18. A particulate matter: How environmental irritants and particulate matter increase sensitivity to bacterial respiratory tract infections. Commentary for “Underground railway particulate matter and susceptibility to pneumococcal infection”
  19. Influence of the Polysaccharide Capsule on the Bactericidal Activity of Indolicidin on Streptococcus pneumoniae
  20. Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis
  21. Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women
  22. Capsule Independent Antimicrobial Activity Induced by Nanochitosan against Streptococcus pneumoniae
  23. A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age
  24. HAMLET a human milk protein‐lipid complex induces a pro‐inflammatory phenotype of myeloid cells
  25. The serine protease HtrA plays a key role in heat-induced dispersal of pneumococcal biofilms
  26. A Role of Epithelial Cells and Virulence Factors in Biofilm Formation by Streptococcus pyogenesIn Vitro
  27. Niche- and Gender-Dependent Immune Reactions in Relation to the Microbiota Profile in Pediatric Patients with Otitis Media with Effusion
  28. A Murine Model for Enhancement ofStreptococcus pneumoniaePathogenicity Upon Viral Infection and Advanced Age
  29. Chapter 7 – Pathogenesis of otitis media – A review of the literature between 2015 and 2019
  30. The human milk protein-lipid complex HAMLET disrupts glycolysis and induces death in Streptococcus pneumoniae
  31. HAMLET, a Protein Complex from Human Milk, Has Bactericidal Activity and Enhances the Activity of Antibiotics against Pathogenic Streptococci
  32. Growing and Characterizing Biofilms Formed by Streptococcus pneumoniae
  33. A Protein Complex from Human Milk Enhances the Activity of Antibiotics and Drugs againstMycobacterium tuberculosis
  34. BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state
  35. Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection
  36. Streptococcus pneumoniae Modulates Staphylococcus aureus Biofilm Dispersion and the Transition from Colonization to Invasive Disease
  37. Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies
  38. Panel 6: Vaccines
  39. Panel 4: Report of the Microbiology Panel
  40. Low NF-κB Activation and Necroptosis in Alveolar Macrophages: A New Virulence Property of Streptococcus pneumoniae
  41. In Vitro and In Vivo Biofilm Formation by Pathogenic Streptococci
  42. Host Physiologic Changes Induced by Influenza A Virus Lead toStaphylococcus aureusBiofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease
  43. In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector
  44. Directed vaccination against pneumococcal disease
  45. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization
  46. Structure and Potential Cellular Targets of HAMLET-like Anti-Cancer Compounds made from Milk Components
  47. Halothane Modulates the Type I Interferon Response to Influenza and Minimizes the Risk of Secondary Bacterial Pneumonia through Maintenance of Neutrophil Recruitment in an Animal Model
  48. Absence of capsule reveals glycan-mediated binding and recognition of salivary mucin MUC7 byStreptococcus pneumoniae
  49. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease
  50. Protective effects of human milk antimicrobial peptides against bacterial infection
  51. Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation
  52. Pneumococcal Genetic Transformation During Colonization and Biofilm Formation
  53. Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design
  54. Dynamic Changes in the Streptococcus pneumoniae Transcriptome during Transition from Biofilm Formation to Invasive Disease upon Influenza A Virus Infection
  55. Hybrid bio-synthetic gene delivery
  56. Monitoring Changes in Membrane Polarity, Membrane Integrity, and Intracellular Ion Concentrations in Streptococcus pneumoniae Using Fluorescent Dyes
  57. Pneumococcal Adaptive Responses to Changing Host Environments
  58. Small‐angle X‐ray scattering of BAMLET at pH 12: A complex of α‐lactalbumin and oleic acid
  59. Streptococcus pyogenes Biofilm Growth In Vitro and In Vivo and Its Role in Colonization, Virulence, and Genetic Exchange
  60. Biofilm Formation Enhances Fomite Survival of Streptococcus pneumoniae and Streptococcus pyogenes
  61. A Complex of Equine Lysozyme and Oleic Acid with Bactericidal Activity against Streptococcus pneumoniae
  62. Internalization and Trafficking of Nontypeable Haemophilus influenzae in Human Respiratory Epithelial Cells and Roles of IgA1 Proteases for Optimal Invasion and Persistence
  63. Interkingdom Signaling Induces Streptococcus pneumoniae Biofilm Dispersion and Transition from Asymptomatic Colonization to Disease
  64. Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET
  65. High Levels of Genetic Recombination during Nasopharyngeal Carriage and Biofilm Formation in Streptococcus pneumoniae
  66. The Human Milk Protein-Lipid Complex HAMLET Sensitizes Bacterial Pathogens to Traditional Antimicrobial Agents
  67. A Novel Initiation Mechanism of Death in Streptococcus pneumoniae Induced by the Human Milk Protein-Lipid Complex HAMLET and Activated during Physiological Death
  68. Pneumococcal Interactions with Epithelial Cells Are Crucial for Optimal Biofilm Formation and ColonizationIn VitroandIn Vivo
  69. Oleic acid is a key cytotoxic component of HAMLET-like complexes
  70. A novel method for preparation of HAMLET-like protein complexes
  71. Role of Dihydrolipoamide Dehydrogenase in Regulation of Raffinose Transport in Streptococcus pneumoniae
  72. Apoptosis-Like Death in Bacteria Induced by HAMLET, a Human Milk Lipid-Protein Complex
  73. Streptolysin O Inhibits Clathrin-Dependent Internalization of Group A Streptococcus
  74. PerR Confers Phagocytic Killing Resistance and Allows Pharyngeal Colonization by Group A Streptococcus
  75. Enzymatic Characterization of Dihydrolipoamide Dehydrogenase from Streptococcus pneumoniae Harboring Its Own Substrate
  76. Mg2+ signalling defines the group A streptococcal CsrRS (CovRS) regulon
  77. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae
  78. Enhancement of Streptolysin O Activity and Intrinsic Cytotoxic Effects of the Group A Streptococcal Toxin, NAD-Glycohydrolase
  79. Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signalling
  80. Cytolysin-dependent evasion of lysosomal killing
  81. Relative Roles of Genetic Background and Variation in PspA in the Ability of Antibodies to PspA To Protect against Capsular Type 3 and 4 Strains of Streptococcus pneumoniae
  82. Regions of PspA/EF3296 Best Able To Elicit Protection against Streptococcus pneumoniae in a Murine Infection Model
  83. Characterization of the dihydrolipoamide dehydrogenase from Streptococcus pneumoniae and its role in pneumococcal infection
  84. Hamlet — A Complex from Human Milk that Induces Apoptosis in Tumor Cells but Spares Healthy Cells
  85. In Vivo Activation of Dendritic Cells and T Cells during Salmonella enterica Serovar Typhimurium Infection
  86. Characterization of Binding of Human Lactoferrin to Pneumococcal Surface Protein A
  87. Morphological and functionalin vitroandin vivocharacterization of the mouse corpus cavernosum
  88. A folding variant of human α‐lactalbumin induces mitochondrial permeability transition in isolated mitochondria
  89. Conversion of α-lactalbumin to a protein inducing apoptosis
  90. A folding variant of α‐lactalbumin with bactericidal activity against Streptococcus pneumoniae
  91. A folding variant of α‐lactalbumin with bactericidal activity against Streptococcus pneumoniae
  92. Protease Activation in Apoptosis Induced by MAL
  93. Molecular Characterization of  -Lactalbumin Folding Variants That Induce Apoptosis in Tumor Cells
  94. Multimeric α-Lactalbumin from Human Milk Induces Apoptosis through a Direct Effect on Cell Nuclei
  95. Aspects on the Interaction ofStreptococcus pneumoniaeandHaemophilus influenzaewith Human Respiratory Tract Mucosa
  96. Antibodies to pneumococcal polysaccharides in human milk: lack of relationship to colonization and acute otitis media
  97. Apoptosis induced by a human milk protein.